Literature DB >> 23547815

Circulating miR-122 as a potential biomarker of liver disease.

Omar F Laterza1, Mitchell G Scott, Philip W Garrett-Engele, Kevin M Korenblat, Christina M Lockwood.   

Abstract

AIM: Expression profiles indicate that miR-122 is specifically and abundantly expressed in liver. This study sought to determine miR-122 plasma concentrations in 15 apparently healthy subjects and 30 patients with liver disease, and clarify whether plasma miR-122 correlates with ALT. MATERIALS &
METHODS: miR-122 was measured by quantitative PCR in healthy volunteers and patients with liver disease.
RESULTS: ALT was increased in two out of 15 (13%) apparently healthy subjects and 17 out of 30 (57%) liver disease patients. In healthy subjects, median miR-122 plasma concentration was 51.7 copies/20 pg RNA (range 16.0-312.0). In liver disease patients, median miR-122 was significantly elevated to 202.3 copies/20 pg RNA (range 20.9-1160.0; Mann-Whitney test between median concentrations; p = 0.0016).
CONCLUSION: This small proof-of-principle study suggests that miR-122 may be a potential plasma biomarker of liver damage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23547815     DOI: 10.2217/bmm.12.107

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  14 in total

1.  RATEmiRs: the rat atlas of tissue-specific and enriched miRNAs for discerning baseline expression exclusivity of candidate biomarkers.

Authors:  Pierre R Bushel; Florian Caiment; Han Wu; Raegan O'Lone; Frank Day; John Calley; Aaron Smith; Jianying Li; Alison H Harrill
Journal:  RNA Biol       Date:  2020-02-12       Impact factor: 4.652

Review 2.  Alcoholic hepatitis and HCV interactions in the modulation of liver disease.

Authors:  C S Punzalan; T N Bukong; G Szabo
Journal:  J Viral Hepat       Date:  2015-03-06       Impact factor: 3.728

Review 3.  Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise.

Authors:  Warren B Nothnick; Ayman Al-Hendy; John R Lue
Journal:  J Minim Invasive Gynecol       Date:  2015-03-07       Impact factor: 4.137

4.  Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.

Authors:  Xi Yang; William F Salminen; Qiang Shi; James Greenhaw; Pritmohinder S Gill; Sudeepa Bhattacharyya; Richard D Beger; Donna L Mendrick; William B Mattes; Laura P James
Journal:  Toxicol Appl Pharmacol       Date:  2015-02-21       Impact factor: 4.219

Review 5.  Circulating miRNAs as biomarkers for endocrine disorders.

Authors:  H Butz; N Kinga; K Racz; A Patocs
Journal:  J Endocrinol Invest       Date:  2015-05-28       Impact factor: 4.256

Review 6.  Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.

Authors:  Viswam S Nair; Colin C Pritchard; Muneesh Tewari; John P A Ioannidis
Journal:  Am J Epidemiol       Date:  2014-06-24       Impact factor: 4.897

Review 7.  Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers.

Authors:  Chiranjib Chakraborty; Srijit Das
Journal:  Tumour Biol       Date:  2016-01-29

8.  Assay reproducibility in clinical studies of plasma miRNA.

Authors:  Jonathan Rice; Henry Roberts; James Burton; Jianmin Pan; Vanessa States; Shesh N Rai; Susan Galandiuk
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

9.  The Hepatoprotective and MicroRNAs Downregulatory Effects of Crocin Following Hepatic Ischemia-Reperfusion Injury in Rats.

Authors:  Ghaidafeh Akbari; Seyyed Ali Mard; Mahin Dianat; Esrafil Mansouri
Journal:  Oxid Med Cell Longev       Date:  2017-03-06       Impact factor: 6.543

Review 10.  MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  J Clin Med       Date:  2015-05-20       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.